As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 4/29/24  Addex Therapeutics Ltd.           6-K         4/29/24    2:16K                                    Globenewswire Inc./FA    
 4/18/24  Addex Therapeutics Ltd.           POS AM                 2:1.4M                                   Toppan Merrill/FA        
 4/18/24  Addex Therapeutics Ltd.           20-F       12/31/23  118:15M                                    Toppan Merrill/FA        
 4/18/24  Addex Therapeutics Ltd.           6-K         4/18/24    2:23K                                    Globenewswire Inc./FA    
  4/3/24  Addex Therapeutics Ltd.           6-K          4/3/24    2:19K                                    Globenewswire Inc./FA    
 1/30/24  Addex Therapeutics Ltd.           6-K         1/30/24    3:269K                                   Toppan Merrill/FA        
12/21/23  Addex Therapeutics Ltd.           6-K/A       6/30/23   76:6.3M                                   Toppan Merrill/FA        
12/20/23  Addex Therapeutics Ltd.           6-K        12/20/23    2:13K                                    Globenewswire Inc./FA    
12/14/23  Addex Therapeutics Ltd.           6-K        12/14/23    2:14K                                    Globenewswire Inc./FA    
11/29/23  Addex Therapeutics Ltd.           POS AM                 2:542K                                   Toppan Merrill/FA        
11/28/23  Addex Therapeutics Ltd.           6-K        11/28/23    2:13K                                    Globenewswire Inc./FA    
11/14/23  Addex Therapeutics Ltd.           6-K        11/14/23    2:17K                                    Globenewswire Inc./FA    
 11/8/23  Addex Therapeutics Ltd.           6-K         11/8/23    2:13K                                    Globenewswire Inc./FA    
10/20/23  Addex Therapeutics Ltd.           6-K        10/20/23    2:15K                                    Globenewswire Inc./FA    
 10/6/23  Citibank, N.A./ADR                F-6 POS                3:653K Addex Therapeutics Ltd.           E-Data Systems, Inc./FA  
 10/6/23  Addex Therapeutics Ltd.           6-K         10/6/23    2:15K                                    Globenewswire Inc./FA    
 9/20/23  Addex Therapeutics Ltd.           6-K         9/20/23    2:17K                                    Globenewswire Inc./FA    
  9/5/23  Addex Therapeutics Ltd.           6-K          9/5/23    2:17K                                    Globenewswire Inc./FA    
  9/5/23  Addex Therapeutics Ltd.           6-K          9/4/23    2:16K                                    Globenewswire Inc./FA    
 8/10/23  Addex Therapeutics Ltd.           POS AM                 5:1.5M                                   Toppan Merrill/FA        

____________
¹	Filing/Form Types:
	6-K	Current, Quarterly or Annual Report by a Foreign Issuer — Form 6-K.
	20-F	Annual or Annual-Transition Report by a Foreign Non-Canadian Issuer — Form 20-F.
	F-6 POS	Post-Effective Amendment of an ‘F-6EF’ Registration — Form F-6.
	POS AM	Post-Effective Amendment of a Registration Statement.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.